{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T10:32:06Z","timestamp":1793442726206,"version":"4.5.0"},"reference-count":133,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["2025.02193.BD"],"award-info":[{"award-number":["2025.02193.BD"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jconrel.2026.115415","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T06:19:59Z","timestamp":1790576399000},"page":"115415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"PB","title":["Nanoparticles reshaping graft-versus-host disease landscape"],"prefix":"10.1016","volume":"399","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2544-4030","authenticated-orcid":false,"given":"Leonardo Maia","family":"Mo\u00e7o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5763-7553","authenticated-orcid":false,"given":"Bruno","family":"Sarmento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3476-0211","authenticated-orcid":false,"given":"Delfim","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.115415_bb0005","doi-asserted-by":"crossref","first-page":"33","DOI":"10.12968\/hmed.2019.80.1.33","article-title":"Haematopoietic stem cell transplants: principles and indications","volume":"80","author":"Balassa","year":"2019","journal-title":"Br. J. Hosp. Med. (Lond.)"},{"key":"10.1016\/j.jconrel.2026.115415_bb0010","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrc2804","article-title":"Allogeneic haematopoietic stem cell transplantation: individualized stem cell and immune therapy of cancer","volume":"10","author":"Jenq","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.115415_bb0015","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","article-title":"Graft-versus-leukemia reactions after bone marrow transplantation","volume":"75","author":"Horowitz","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2026.115415_bb0020","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.70647","article-title":"Nanotechnology in hematology: enhancing therapeutic efficacy with nanoparticles","volume":"8","author":"Fard","year":"2025","journal-title":"Health Sci. Rep."},{"key":"10.1016\/j.jconrel.2026.115415_bb0025","doi-asserted-by":"crossref","first-page":"958","DOI":"10.3324\/haematol.2016.156356","article-title":"Improved survival after acute graft-versus-host disease diagnosis in the modern era","volume":"102","author":"Khoury","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.jconrel.2026.115415_bb0030","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-023-00438-1","article-title":"Acute graft-versus-host disease","volume":"9","author":"Malard","year":"2023","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jconrel.2026.115415_bb0035","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1126\/science.285.5426.412","article-title":"Prevention of graft versus host disease by inactivation of host antigen-presenting cells","volume":"285","author":"Shlomchik","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.115415_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2022.12.024","article-title":"Chronic graft-versus-host disease. Part I: epidemiology, pathogenesis, and clinical manifestations","volume":"90","author":"Baumrin","year":"2024","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jconrel.2026.115415_bb0045","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1182\/blood.2019000953","article-title":"Immunopathology and biology-based treatment of steroid-refractory graft-versus-host disease","volume":"136","author":"Toubai","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2026.115415_bb0050","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/ncprheum0898","article-title":"Genomic and nongenomic effects of glucocorticoids","volume":"4","author":"Stahn","year":"2008","journal-title":"Nat. Clin. Pract. Rheumatol."},{"key":"10.1016\/j.jconrel.2026.115415_bb0055","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1182\/bloodadvances.2020002097","article-title":"The development of ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease","volume":"4","author":"Zeiser","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.jconrel.2026.115415_bb0060","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/S2352-3026(19)30256-X","article-title":"Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation","volume":"7","author":"Penack","year":"2020","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.jconrel.2026.115415_bb0065","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1038\/s41409-019-0544-y","article-title":"Retrospective single center analysis of outcome, risk factors and therapy in steroid refractory graft-versus-host disease after allogeneic hematopoietic cell transplantation","volume":"54","author":"Axt","year":"2019","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.jconrel.2026.115415_bb0070","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1182\/blood-2017-07-793786","article-title":"Ibrutinib for chronic graft-versus-host disease after failure of prior therapy","volume":"130","author":"Miklos","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2026.115415_bb0075","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/s41409-025-02554-w","article-title":"Efficacy and safety of belumosudil for treatment of cGVHD: multicenter retrospective analysis of the French cohort of the compassionate use program, on behalf of the French Society of Bone Marrow Transplantation and Cellular Therapy","volume":"60","author":"Michonneau","year":"2025","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.jconrel.2026.115415_bb0080","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/S2352-3026(23)00342-3","article-title":"Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation","volume":"11","author":"Penack","year":"2024","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.jconrel.2026.115415_bb0085","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/bmt.2010.5","article-title":"Impact of GvHD on quality of life in long-term survivors of haematopoietic transplantation","volume":"45","author":"Pallua","year":"2010","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.jconrel.2026.115415_bb0090","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1089\/jayao.2021.0196","article-title":"Graft-versus-host-disease and health-related quality of life in young long-term survivors of Cancer and allogeneic hematopoietic stem cell transplantation","volume":"12","author":"Diep","year":"2023","journal-title":"J. Adolesc. Young Adult Oncol."},{"key":"10.1016\/j.jconrel.2026.115415_bb0095","doi-asserted-by":"crossref","first-page":"10552","DOI":"10.1182\/blood-2022-167820","article-title":"Effects of severe acute graft-versus-host disease on quality of life, medical comorbidities and survival","volume":"140","author":"Rashid","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2026.115415_bb0100","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/s41409-023-01930-8","article-title":"Clinical and economic burden associated with graft-versus-host disease following allogeneic hematopoietic cell transplantation in France","volume":"58","author":"Michonneau","year":"2023","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.jconrel.2026.115415_bb0105","first-page":"217","article-title":"The multiple mixed lymphocyte reaction: variables important in the test as a measure of lymphocyte competence in man","volume":"48","author":"Mangi","year":"1975","journal-title":"Yale J. Biol. Med."},{"key":"10.1016\/j.jconrel.2026.115415_bb0110","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/CJI.0000000000000071","article-title":"Efficient nontoxic delivery of PD-L1 and PD-L2 siRNA into dendritic cell vaccines using the cationic lipid SAINT-18","volume":"38","author":"Roeven","year":"2015","journal-title":"J. Immunother."},{"key":"10.1016\/j.jconrel.2026.115415_bb0115","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1038\/s41467-022-31130-9","article-title":"Selective activation and expansion of regulatory T cells using lipid encapsulated mRNA encoding a long-acting IL-2 mutein","volume":"13","author":"de Picciotto","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115415_bb0120","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","article-title":"Of mice and not men: differences between mouse and human immunology","volume":"172","author":"Mestas","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2026.115415_bb0125","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1242\/dmm.006668","article-title":"Mouse models of graft-versus-host disease: advances and limitations","volume":"4","author":"Schroeder","year":"2011","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.jconrel.2026.115415_bb0130","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1182\/blood-2016-02-699082","article-title":"Preclinical models of acute and chronic graft-versus-host disease: how predictive are they for a successful clinical translation?","volume":"127","author":"Zeiser","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2026.115415_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00333","article-title":"The role of animal models in the study of hematopoietic stem cell transplantation and GvHD: a historical overview","volume":"7","author":"Boieri","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115415_bb0140","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1084\/jem.165.6.1552","article-title":"Variable capacity of L3T4+ T cells to cause lethal graft-versus-host disease across minor histocompatibility barriers in mice","volume":"165","author":"Korngold","year":"1987","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2026.115415_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2023.103125","article-title":"Rapamycin nanoparticles increase the therapeutic window of engineered interleukin-2 and drive expansion of antigen-specific regulatory T cells for protection against autoimmune disease","volume":"140","author":"Kishimoto","year":"2023","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jconrel.2026.115415_bb0150","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jconrel.2024.01.015","article-title":"Nanoparticles targeting the intestinal fc receptor enhance intestinal cellular trafficking of semaglutide","volume":"366","author":"Pinto","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115415_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122875","article-title":"Exploring the potential of human intestinal organoids: applications, challenges, and future directions","volume":"352","author":"Parente","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.jconrel.2026.115415_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1253514","article-title":"Novel T cell\/organoid culture system allows ex vivo modeling of intestinal graft-versus-host disease","volume":"14","author":"Matthe","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115415_bb0165","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/eji.201948464","article-title":"Glucocorticoids delivered by inorganic-organic hybrid nanoparticles mitigate acute graft-versus-host disease and sustain graft-versus-leukemia activity","volume":"50","author":"Kaiser","year":"2020","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jconrel.2026.115415_bb0170","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008663","article-title":"Immune isolation-enabled nanoencapsulation of donor T cells: a promising strategy for mitigating GVHD and treating AML in preclinical models","volume":"12","author":"Mei","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2026.115415_bb0175","article-title":"Advances and applications of nanoparticles in cancer therapy","volume":"3","author":"Huang","year":"2024","journal-title":"MedComm Oncol."},{"key":"10.1016\/j.jconrel.2026.115415_bb0180","article-title":"Nanoparticle-based drug delivery Systems for Induction of tolerance and treatment of autoimmune diseases","volume":"10","author":"Li","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115415_bb0185","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/TP.0000000000003032","article-title":"Nanotechnology applications in transplantation medicine","volume":"104","author":"Yao","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.jconrel.2026.115415_bb0190","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s12951-022-01477-8","article-title":"Nanoparticle classification, physicochemical properties, characterization, and applications: a comprehensive review for biologists","volume":"20","author":"Joudeh","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.115415_bb0195","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1155622","article-title":"A review on nanoparticles: characteristics, synthesis, applications, and challenges","volume":"14","author":"Altammar","year":"2023","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jconrel.2026.115415_bb0200","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1021\/acsmaterialsau.3c00032","article-title":"Lipid-based nanoparticles for drug\/gene delivery: an overview of the production techniques and difficulties encountered in their industrial development","volume":"3","author":"Mehta","year":"2023","journal-title":"ACS Mater. Au"},{"key":"10.1016\/j.jconrel.2026.115415_bb0205","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pharmthera.2016.03.007","article-title":"A comprehensive review of the neonatal fc receptor and its application in drug delivery","volume":"161","author":"Martins","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2026.115415_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1081\/LPR-120039660","article-title":"Transendothelial movement of liposomes in vitro mediated by cancer cells, neutrophils or histamine","volume":"14","author":"Antohe","year":"2004","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.jconrel.2026.115415_bb0215","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.115415_bb0220","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41573-019-0017-4","article-title":"The current state and future directions of RNAi-based therapeutics","volume":"18","author":"Setten","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.115415_bb0225","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.4049\/jimmunol.1101604","article-title":"Liposomal encapsulation of glucocorticoids alters their mode of action in the treatment of experimental autoimmune encephalomyelitis","volume":"187","author":"Schweingruber","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2026.115415_bb0230","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.893659","article-title":"Post transplantation bilirubin nanoparticles ameliorate murine graft versus host disease via a reduction of systemic and local inflammation","volume":"13","author":"Pareek","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115415_bb0235","article-title":"mRNA-delivery of IDO1 suppresses T cell-mediated autoimmunity","volume":"5","author":"Kenney","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.jconrel.2026.115415_bb0240","first-page":"10","article-title":"Evaluation of experimental immunotherapeutic formulations in the hybrid murine model of graft-versus-host reaction","volume":"19","author":"Ying","year":"2020","journal-title":"Rev. Habanera Cienc. Med."},{"key":"10.1016\/j.jconrel.2026.115415_bb0245","article-title":"Galectin-3 is a nanotherapeutic target in graft-versus-host disease mediated kidney injury","author":"Panagiotakopoulou","year":"2025","journal-title":"bioRxiv [Preprint]"},{"key":"10.1016\/j.jconrel.2026.115415_bb0250","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1021\/acs.chemrev.3c00705","article-title":"Polymeric nanoparticles for drug delivery","volume":"124","author":"Beach","year":"2024","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2026.115415_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176517","article-title":"Influence of nanoparticle-mediated transfection on proliferation of primary immune cells in vitro and in vivo","volume":"12","author":"Przybylski","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2026.115415_bb0260","doi-asserted-by":"crossref","first-page":"6189","DOI":"10.1021\/acsnano.6b02206","article-title":"Conformal Nanoencapsulation of allogeneic T cells mitigates graft-versus-host disease and retains graft-versus-leukemia activity","volume":"10","author":"Zhao","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115415_bb0265","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.jconrel.2026.115415_bb0270","doi-asserted-by":"crossref","first-page":"1429335","DOI":"10.3389\/fimmu.2024.1429335","article-title":"Nanoparticles loaded with IL-2 and TGF-beta promote transplantation tolerance to alloantigen","volume":"15","author":"Horwitz","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115415_bb0275","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1587237","article-title":"CD2-targeted nanoparticles encapsulating IL-2 induce tolerogenic Tregs and TGF-beta-producing NK cells that stabilize Tregs for long-term therapeutic efficacy in immune-mediated disorders","volume":"16","author":"Horwitz","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115415_bb0280","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.628059","article-title":"Nanoparticles engineered as artificial antigen-presenting cells induce human CD4(+) and CD8(+) Tregs that are functional in humanized mice","volume":"12","author":"Giang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115415_bb0285","first-page":"68","article-title":"The basics of artificial antigen presenting cells in T cell-based cancer immunotherapies","volume":"2","author":"Neal","year":"2017","journal-title":"J. Immunol. Res. Ther."},{"key":"10.1016\/j.jconrel.2026.115415_bb0290","doi-asserted-by":"crossref","DOI":"10.3390\/cancers18091431","article-title":"Myeloid cell-targeting PLGA nanoparticles ameliorate acute graft-versus-host disease","volume":"18","author":"Galvin","year":"2026","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jconrel.2026.115415_bb0295","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/adhm.201300023","article-title":"Nano-graphene oxide: a potential multifunctional platform for cancer therapy","volume":"2","author":"Goncalves","year":"2013","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2026.115415_bb0300","article-title":"Nanographene oxide attenuates acute GVHD by modulating macrophage polarization in a xenogeneic mouse model","volume":"12","author":"Yu","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.jconrel.2026.115415_bb0305","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1208\/s12248-015-9780-2","article-title":"A review of clinical translation of inorganic nanoparticles","volume":"17","author":"Anselmo","year":"2015","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2026.115415_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e18404","article-title":"In-situ preparation of norepinephrine-functionalized silver nanoparticles and application for colorimetric detection of tacrolimus in plasma samples","volume":"9","author":"Golsanamlu","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.jconrel.2026.115415_bb0315","doi-asserted-by":"crossref","first-page":"4770","DOI":"10.4049\/jimmunol.181.7.4770","article-title":"Impact of mammalian target of rapamycin inhibition on lymphoid homing and tolerogenic function of nanoparticle-labeled dendritic cells following allogeneic hematopoietic cell transplantation","volume":"181","author":"Reichardt","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2026.115415_bb0320","doi-asserted-by":"crossref","first-page":"6510","DOI":"10.1007\/s11664-020-08415-0","article-title":"Cleavable, covalently linked, affinity coupling immune magnetic nanoparticles for specifically depleting T cells","volume":"49","author":"Huynh","year":"2020","journal-title":"J. Electron. Mater."},{"key":"10.1016\/j.jconrel.2026.115415_bb0325","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.2147\/IJN.S24567","article-title":"Prevention of acute graft-versus-host disease by magnetic nanoparticles of Fe3O4 combined with cyclosporin a in murine models","volume":"6","author":"Cheng","year":"2011","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.115415_bb0330","doi-asserted-by":"crossref","first-page":"458","DOI":"10.4103\/ijp.IJP_536_16","article-title":"Immunomodulatory properties of titanium dioxide nanostructural materials","volume":"49","author":"Latha","year":"2017","journal-title":"Indian J. Pharm."},{"key":"10.1016\/j.jconrel.2026.115415_bb0335","doi-asserted-by":"crossref","DOI":"10.3390\/nano9091197","article-title":"Organic-inorganic hybrid nanomaterials","volume":"9","author":"Ananikov","year":"2019","journal-title":"Nanomaterials"},{"key":"10.1016\/j.jconrel.2026.115415_bb0340","doi-asserted-by":"crossref","first-page":"7329","DOI":"10.1021\/jacs.5b01172","article-title":"Multifunctional phosphate-based inorganic-organic hybrid nanoparticles","volume":"137","author":"Heck","year":"2015","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.115415_bb0345","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/jbm.a.37356","article-title":"Rational design of anti-inflammatory lipid nanoparticles for mRNA delivery","volume":"110","author":"Zhang","year":"2022","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.jconrel.2026.115415_bb0350","article-title":"Ionizable lipid-dependent optimization of steroid lipid nanoparticles with tunable immunomodulatory properties","volume":"74301","author":"Thatte","year":"2026","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115415_bb0355","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.00790","article-title":"Current trends and challenges in the clinical translation of nanoparticulate nanomedicines: pathways for translational development and commercialization","volume":"9","author":"Hua","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.115415_bb0360","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2991\/chi.d.190314.001","article-title":"Challenges in conducting studies in chronic graft-versus-host disease","volume":"1","author":"Pusic","year":"2019","journal-title":"Clin. Hematol. Int."},{"key":"10.1016\/j.jconrel.2026.115415_bb0365","series-title":"the EBMT handbook: hematopoietic stem cell transplantation and cellular therapies","first-page":"331","article-title":"Chronic graft-versus-host disease","author":"Wolff","year":"2019"},{"key":"10.1016\/j.jconrel.2026.115415_bb0370","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/MOH.0000000000000026","article-title":"Graft-versus-host disease: why have we not made more progress?","volume":"21","author":"Jaglowski","year":"2014","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.jconrel.2026.115415_bb0375","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26072923","article-title":"Immune modulation and immunotherapy in solid tumors: mechanisms of resistance and potential therapeutic strategies","volume":"26","author":"Giri","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.115415_bb0380","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s12094-015-1295-x","article-title":"Immunotherapy with liposome-bound TRAIL overcomes partial protection to soluble TRAIL-induced apoptosis offered by down-regulation of Bim in leukemic cells","volume":"17","author":"De Miguel","year":"2015","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.jconrel.2026.115415_bb0385","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1038\/s41467-017-01830-8","article-title":"T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity","volume":"8","author":"Schmid","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115415_bb0390","article-title":"Antigen presenting cell mimetic lipid nanoparticles for rapid mRNA CAR T cell cancer immunotherapy","volume":"36","author":"Metzloff","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115415_bb0395","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s40290-022-00428-w","article-title":"Barriers to chimeric antigen receptor T-cell (CAR-T) therapies in clinical practice","volume":"36","author":"Gajra","year":"2022","journal-title":"Pharm. Med."},{"key":"10.1016\/j.jconrel.2026.115415_bb0400","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1126\/science.ads8473","article-title":"In vivo CAR T cell generation to treat cancer and autoimmune disease","volume":"388","author":"Hunter","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.115415_bb0405","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202301515","article-title":"Ionizable lipid nanoparticles with integrated immune checkpoint inhibition for mRNA CAR T cell engineering","volume":"12","author":"Hamilton","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2026.115415_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2024.102518","article-title":"In situ engineering of mRNA-CAR T cells using spleen-targeted ionizable lipid nanoparticles to eliminate cancer cells","volume":"59","author":"Li","year":"2024","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2026.115415_bb0415","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.ade6967","article-title":"In vivo hematopoietic stem cell modification by mRNA delivery","volume":"381","author":"Breda","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.115415_bb0420","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.2217\/nnm-2018-0501","article-title":"Peptide-targeted liposomal delivery of dexamethasone for arthritis therapy","volume":"14","author":"Meka","year":"2019","journal-title":"Nanomedicine (London)"},{"key":"10.1016\/j.jconrel.2026.115415_bb0425","doi-asserted-by":"crossref","DOI":"10.1186\/ar2889","article-title":"Separating therapeutic efficacy from glucocorticoid side-effects in rodent arthritis using novel, liposomal delivery of dexamethasone phosphate: long-term suppression of arthritis facilitates interval treatment","volume":"11","author":"Rauchhaus","year":"2009","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jconrel.2026.115415_bb0430","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1002\/art.11140","article-title":"Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes","volume":"48","author":"Metselaar","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jconrel.2026.115415_bb0435","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/brain\/awg176","article-title":"Drug targeting by long-circulating liposomal glucocorticosteroids increases therapeutic efficacy in a model of multiple sclerosis","volume":"126","author":"Schmidt","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.jconrel.2026.115415_bb0440","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-019-1449-1","article-title":"A lipid micellar system loaded with dexamethasone palmitate alleviates rheumatoid arthritis","volume":"20","author":"Wang","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2026.115415_bb0445","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.exer.2005.09.003","article-title":"Treatment of experimental autoimmune uveoretinitis with poly(lactic acid) nanoparticles encapsulating betamethasone phosphate","volume":"82","author":"Sakai","year":"2006","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jconrel.2026.115415_bb0450","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1124\/jpet.108.150276","article-title":"Treatment of experimental arthritis with stealth-type polymeric nanoparticles encapsulating betamethasone phosphate","volume":"329","author":"Ishihara","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2026.115415_bb0455","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cellimm.2009.07.004","article-title":"Effect of betamethasone phosphate loaded polymeric nanoparticles on a murine asthma model","volume":"260","author":"Matsuo","year":"2009","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.jconrel.2026.115415_bb0460","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1007\/s13346-021-01112-3","article-title":"Improving dexamethasone drug loading and efficacy in treating arthritis through a lipophilic prodrug entrapped into PLGA-PEG nanoparticles","volume":"12","author":"Simon-Vazquez","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2026.115415_bb0465","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jconrel.2019.01.015","article-title":"Dexamethasone palmitate nanoparticles: an efficient treatment for rheumatoid arthritis","volume":"296","author":"Lorscheider","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115415_bb0470","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jconrel.2012.06.022","article-title":"Enhanced brain delivery of liposomal methylprednisolone improved therapeutic efficacy in a model of neuroinflammation","volume":"164","author":"Gaillard","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115415_bb0475","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/TP.0000000000003060","article-title":"Liposomal delivery improves the efficacy of prednisolone to attenuate renal inflammation in a mouse model of acute renal allograft rejection","volume":"104","author":"van Alem","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.jconrel.2026.115415_bb0480","doi-asserted-by":"crossref","DOI":"10.1007\/s11033-024-09764-3","article-title":"Ruxolitinib-loaded poly-varepsilon-caprolactone (PCL) nanoparticles inhibit JAK2\/STAT5 signaling in BT474 breast cancer cells by downregulating Bcl-2 and Mcl-1","volume":"51","author":"Celik","year":"2024","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.jconrel.2026.115415_bb0485","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00262-025-04096-y","article-title":"Cell-specific nanoengineering strategy to disrupt tolerogenic signaling from myeloid-derived suppressor cells and invigorate antitumor immunity in pancreatic cancer","volume":"74","author":"Deshpande","year":"2025","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.jconrel.2026.115415_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124127","article-title":"Ruxolitinib-loaded cytokine nanosponge alleviated the cytokine storm and dampened macrophage overactivation for the treatment of hemophagocytic lymphohistiocytosis","volume":"657","author":"Wang","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.115415_bb0495","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.mehy.2017.09.023","article-title":"Ruxolitinib-conjugated gold nanoparticles for topical administration: an alternative for treating alopecia?","volume":"109","author":"Boca","year":"2017","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.jconrel.2026.115415_bb0500","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/mt.2010.85","article-title":"Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms","volume":"18","author":"Akinc","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2026.115415_bb0505","doi-asserted-by":"crossref","first-page":"123","DOI":"10.7150\/thno.117363","article-title":"Neutrophil-based delivery platforms: from natural mechanisms to engineered therapeutics","volume":"16","author":"Li","year":"2026","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2026.115415_bb0510","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/sj.gt.3301407","article-title":"Receptor-mediated gene delivery to human peripheral blood mononuclear cells using anti-CD3 antibody coupled to polyethylenimine","volume":"8","author":"O\u2019Neill","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2026.115415_bb0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbior.2019.100638","article-title":"The TCR\/CD3 complex in leukemogenesis and as a therapeutic target in T-cell acute lymphoblastic leukemia","volume":"74","author":"Dos Santos","year":"2019","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jconrel.2026.115415_bb0520","doi-asserted-by":"crossref","DOI":"10.1093\/jleuko\/qiae249","article-title":"Transgenic alphabeta TCR tonic signaling is leukemogenic while strong stimulation is leukemia suppressive","volume":"117","author":"Catarino","year":"2025","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jconrel.2026.115415_bb0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121339","article-title":"In situ T-cell transfection by anti-CD3-conjugated lipid nanoparticles leads to T-cell activation, migration, and phenotypic shift","volume":"281","author":"Kheirolomoom","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.115415_bb0530","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1158\/2159-8290.CD-15-0675","article-title":"Triggering the TCR developmental checkpoint activates a therapeutically targetable tumor suppressive pathway in T-cell leukemia","volume":"6","author":"Trinquand","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jconrel.2026.115415_bb0535","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1182\/blood.2019003801","article-title":"Preclinical efficacy of humanized, non-FcgammaR-binding anti-CD3 antibodies in T-cell acute lymphoblastic leukemia","volume":"136","author":"Tran Quang","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2026.115415_bb0540","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.4049\/jimmunol.166.9.5835","article-title":"Anti-CD3 epsilon F(ab\u2019)2 prevents graft-versus-host disease by selectively depleting donor T cells activated by recipient alloantigens","volume":"166","author":"Yu","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2026.115415_bb0545","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.893545","article-title":"Naive T cells in graft versus host disease and graft versus leukemia: innocent or guilty?","volume":"13","author":"Dekker","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115415_bb0550","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.1182\/blood-2009-12-260539","article-title":"Leukemia-associated minor histocompatibility antigen discovery using T-cell clones isolated by in vitro stimulation of naive CD8+ T cells","volume":"115","author":"Bleakley","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2026.115415_bb0555","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.761448","article-title":"T cell subsets in graft versus host disease and graft versus tumor","volume":"12","author":"Jiang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115415_bb0560","article-title":"Selective depletion of naive T cells by targeting CD45RA","volume":"12","author":"Naik","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jconrel.2026.115415_bb0565","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1284936","article-title":"Mesenchymal stem cell-derived exosomes can alleviate GVHD and preserve the GVL effect in allogeneic stem cell transplantation animal models","volume":"14","author":"Jiang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115415_bb0570","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24044084","article-title":"Graft-versus-host disease modulation by innate T cells","volume":"24","author":"Fang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.115415_bb0575","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jim.2013.04.004","article-title":"In vivo depletion of leukocytes and platelets following injection of T cell-specific antibodies into mice","volume":"393","author":"Loubaki","year":"2013","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jconrel.2026.115415_bb0580","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1111\/ajt.13394","article-title":"Innate lymphoid cells in graft-versus-host disease","volume":"15","author":"Konya","year":"2015","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.jconrel.2026.115415_bb0585","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.immuni.2014.09.005","article-title":"Development, differentiation, and diversity of innate lymphoid cells","volume":"41","author":"Diefenbach","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2026.115415_bb0590","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.immuni.2012.05.028","article-title":"Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease","volume":"37","author":"Hanash","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2026.115415_bb0595","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood-2013-11-536888","article-title":"Activated innate lymphoid cells are associated with a reduced susceptibility to graft-versus-host disease","volume":"124","author":"Munneke","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2026.115415_bb0600","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood-2006-01-0233","article-title":"Rituximab for steroid-refractory chronic graft-versus-host disease","volume":"108","author":"Cutler","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2026.115415_bb0605","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/bmt.2016.90","article-title":"AML relapse after rituximab treatment for GvHD: crucial role for B cells in GvL responses","volume":"51","author":"Gillissen","year":"2016","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.jconrel.2026.115415_bb0610","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.bbmt.2010.08.021","article-title":"Evidence of B cell immune responses to acute lymphoblastic leukemia in murine allogeneic hematopoietic stem cell transplantation recipients treated with donor lymphocyte infusion and\/or vaccination","volume":"17","author":"Mullen","year":"2011","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.jconrel.2026.115415_bb0615","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1111\/bjh.19356","article-title":"Increased donor inhibitory KIR are associated with reduced GVHD and improved survival following HLA-matched unrelated donor HCT in paediatric acute leukaemia","volume":"204","author":"Krieger","year":"2024","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jconrel.2026.115415_bb0620","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1033871","article-title":"Donor selection for KIR alloreactivity is associated with superior survival in haploidentical transplant with PTCy","volume":"13","author":"Zou","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115415_bb0625","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2024.103274","article-title":"Reconstituted CD74(+) NK cells trigger chronic graft versus host disease after allogeneic bone marrow transplantation","volume":"147","author":"Dou","year":"2024","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jconrel.2026.115415_bb0630","article-title":"From CAR-T cells to CAR-NK cells: a developing immunotherapy method for hematological malignancies","volume":"11","author":"Lu","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jconrel.2026.115415_bb0635","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1182\/blood-2017-12-823757","article-title":"First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation","volume":"131","author":"Romee","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2026.115415_bb0640","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1182\/blood-2016-02-702852","article-title":"Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease","volume":"128","author":"Koreth","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2026.115415_bb0645","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/j.bbmt.2014.08.005","article-title":"Host-derived CD8(+) dendritic cells protect against acute graft-versus-host disease after experimental allogeneic bone marrow transplantation","volume":"20","author":"Weber","year":"2014","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.jconrel.2026.115415_bb0650","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1182\/blood-2011-11-364091","article-title":"Dendritic cells and regulation of graft-versus-host disease and graft-versus-leukemia activity","volume":"119","author":"Stenger","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2026.115415_bb0655","doi-asserted-by":"crossref","first-page":"15437","DOI":"10.18632\/oncotarget.24602","article-title":"The glucocorticoid receptor in recipient cells keeps cytokine secretion in acute graft-versus-host disease at bay","volume":"9","author":"Baake","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.jconrel.2026.115415_bb0660","series-title":"Basics of Hematopoietic Stem Cell Transplant","first-page":"609","article-title":"Chronic graft-versus-host disease","author":"Sharma","year":"2023"},{"key":"10.1016\/j.jconrel.2026.115415_bb0665","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jconrel.2007.08.014","article-title":"Serum insensitive, intranuclear protein delivery by the multipurpose cationic lipid SAINT-2","volume":"123","author":"van der Gun","year":"2007","journal-title":"J. Control. Release"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926008199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926008199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T09:51:51Z","timestamp":1793440311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926008199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":133,"alternative-id":["S0168365926008199"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115415","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanoparticles reshaping graft-versus-host disease landscape","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115415","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115415"}}